Boiron SA (BOI.PA)

34,05 -0,25 (-0,73%) Al cierre: 05:35PM CEST

Boiron SA

2, avenue de l’Ouest Lyonnais
Messimy 69510
France
33 4 78 45 61 00
https://www.boiron.fr

Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 2813

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Ms. Valérie Lorentz-Poinsot	GM & Executive Director	988,23k	N/A	1969
Mr. Jean-Christophe Bayssat	Deputy GM, Chief Pharmacist & Director of Pharmaceutical Development	411,97k	N/A	1963
Mr. Eric Lambert	Secretary General and Chief Financial & Administrative Officer	N/A	N/A	N/A
Mr. Patrice Varraut	Director of Operations	N/A	N/A	N/A
Ms. Juliette Baudry	Human Resources Director	N/A	N/A	N/A
Fabrice Rey	Group Treasurer	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Gobierno corporativo

El ISS Governance QualityScore de Boiron SA, a día 1 de mayo de 2024, es 10. Las puntuaciones base son Auditoría: 9; Tablero: 10; Derechos de los accionistas: 6; Compensación: 9.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.